The US Food and Drug Administration’s drug safety recommendations and long-acting beta2-agonist dispensing pattern changes in adult asthma patients: 2003–2012

BACKGROUND: Emerging safety issues associated with long-acting beta(2)-agonist (LABA) have led to multiple regulatory activities by the US Food and Drug Administration (FDA) since 2003, including Drug Safety Communications (DSCs) in 2010. These DSCs had three specific recommendations for the safe us...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Esther H, Seymour, Sally, Goulding, Margie R, Kang, Elizabeth M, Major, Jacqueline M, Iyasu, Solomon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360406/
https://www.ncbi.nlm.nih.gov/pubmed/28356763
http://dx.doi.org/10.2147/JAA.S124395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360406/
https://www.ncbi.nlm.nih.gov/pubmed/28356763
http://dx.doi.org/10.2147/JAA.S124395

Ejemplares similares